Skip to main content
HIV/AIDS (Auckland, N.Z.) logoLink to HIV/AIDS (Auckland, N.Z.)
letter
. 2023 May 26;15:267–269. doi: 10.2147/HIV.S419727

“Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia” by Alamneh et al [Letter]

Addisu Dabi Wake 1,✉
PMCID: PMC10228521  PMID: 37260913

Dear editor

I read article entitled “Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia” written by Alamneh et al1 with great passion. Congratulations to the authors. While I was reading this article, I got the wrongly used term, which is not in line with the precision of the used study design. It is significant for the readers if corrected. The issue is this; the objective of this article was

The objective of this study is to determine the magnitude of viral non-suppression rate among pregnant women and identify the risk factors associated with viral non-suppression

by using a cross-sectional study design. The authors have used the term “risk factors” within the entire document.

The term “risk factor” was used in 1961 for the “Framingham Study”, which was focused on “Factors of Risk in the Development of Coronary Heart Disease Six-Year Follow-up Experience”.2 A risk factor is a measurable characterization of each subject in a specified population that precedes the outcome of interest. It is used to divide the population into groups (high-risk and low-risk groups). “The probability of the outcome in the high-risk group of subjects must be shown to be greater than the probability of the outcome in the low risk group”. In a risk assessment study, time needs to be well defined and measured as part of the definition of the outcome.3

A cross-sectional study design is used to assess the selected population at a given period of time and permits to describe the associations between several factors and determine their prevalence. However, this study design does not test cause–effect relationships.4–6 During this, the investigators measure outcomes and exposures of the study subjects at the same time. It is described as taking a “snapshot” of a group of individuals. There is no prospective or retrospective follow-up. The investigators will collect the data and assess the associations between outcomes and exposures.7 It helps to determine the frequencies, exposure level and the relationship or association of the exposure and outcome. However, it cannot distinguish between incidence and natural history for the purpose of causal inference.8 Furthermore, this study design does not test cause–effect relationships.4–6

To identify the risk factors, it is important to measure the incidence. Incidence is typically estimated from clinical trials and from cohort studies, which involve the follow-up of subjects over time.9 Cohort study design allows to create a time sequence for causality and investigate rare exposures to risk factors.4 “Cohort study design is used to compare the group of subjects who are exposed to a certain risk factor with a comparison group who are not exposed”.10 Generally, the prevalence concerns only survivors, so that cases that died prior to the time that prevalence is measured are ignored. Thus, prevalence measures are not as well appropriate as incidence measures for identifying the risk factors.9

Apart from this, the authors used the “odds ratio” for cross-sectional study. However, since the use of “odds ratio” overestimates the association, the use of “prevalence ratio” would have been a better measure of association.11,12 The “prevalence ratio” should be used in preference to the “odds ratio” because it is conservative, consistent, and interpretable.13 The use of “prevalence ratio” in cross-sectional studies should be encouraged since it is easier to interpret. “Prevalence ratio” is the preferred measure of association in cross-sectional studies, which could be easily estimated with the advance of statistical software.14

As a conclusion, considering the mentioned strong epidemiological evidences, we can understand that a cross-sectional study design could not assess “risk factors”. This is because when we say “risk factors”, the exposure should precede the outcome variable. However, the cross-sectional study assesses both exposure and outcome variables at the same time, which does not describe which come first the exposure or outcome variable. Besides, the “risk factors” is determined from the incidence, but cross-sectional study design could not assess the incidence, rather it assesses the prevalence. Moreover, time needs to be well defined and measured as part of the definition of the outcome in a risk assessment study, but this is not suitable in cross-sectional study design.

Therefore, I recommend the authors to replace the term “risk factors” with “associated factors” in the entire document to avoid confusion among the readers of this article. This is because utilizing the most appropriate epidemiological terms in research is very critical for the readers as well as the researchers to have a common understanding that would enhance their knowledge. Lastly, the proper use of statistical techniques when conducting a cross-sectional study must be encouraged to avoid possible inappropriate estimates and interpretations.

Disclosure

The author declares that there is no conflict of interest regarding this communication.

References

  • 1.Alamneh DE, Shiferaw MB, Demissie MG, et al. Virological outcomes among pregnant women receiving antiretroviral treatment in the Amhara Region, North West Ethiopia. HIV. 2023;15:209–216. doi: 10.2147/HIV.S389506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kannel WB. Factors of risk in the development of coronary heart disease—six-year follow-up experience: the Framingham study. Ann Intern Med. 1961;55(1):33. doi: 10.7326/0003-4819-55-1-33 [DOI] [PubMed] [Google Scholar]
  • 3.Kraemer HC. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54(4):337. doi: 10.1001/archpsyc.1997.01830160065009 [DOI] [PubMed] [Google Scholar]
  • 4.Barroga EF, Kojima T. Research study designs: an appraisal for peer reviewers and science editors. Eur Sci Ed. 2013;39:44–45. [Google Scholar]
  • 5.Setia MS. Methodology series module 3: cross-sectional studies. Indian J Dermatol. 2016;61(3):261–264. doi: 10.4103/0019-5154.182410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54–60. doi: 10.1136/emj.20.1.54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1):S65–71. doi: 10.1016/j.chest.2020.03.012 [DOI] [PubMed] [Google Scholar]
  • 8.Rothman K, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins; 2008. [Google Scholar]
  • 9.Kleinbaum DG, Sullivan KM, Barker ND. A Pocket Guide to Epidemiology. New York, NY: Springer New York; 2007. [Google Scholar]
  • 10.Omair A. Selecting the appropriate study design: case–control and cohort study designs. J Health Specialties. 2016;4:37. doi: 10.4103/1658-600X.173842 [DOI] [Google Scholar]
  • 11.Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):21. doi: 10.1186/1471-2288-3-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tamhane AR, Westfall AO, Burkholder GA, Cutter GR. Prevalence odds ratio versus prevalence ratio: choice comes with consequences. Stat Med. 2016;35(30):5730–5735. doi: 10.1002/sim.7059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55(4):272–277. doi: 10.1136/oem.55.4.272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Martinez BAF, Leotti VB, Silva G, Nunes LN, Machado G, Corbellini LG. Odds ratio or prevalence ratio? An overview of reported statistical methods and appropriateness of interpretations in cross-sectional studies with dichotomous outcomes in veterinary medicine. Front Veter Sci. 2017;4. doi: 10.3389/fvets.2017.00193 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from HIV/AIDS (Auckland, N.Z.) are provided here courtesy of Dove Press

RESOURCES